SHANGHAI, March 18 (Xinhua) -- A Chinese research team has developed a multicellular scaffold based on inorganic bioceramics for treating tendon-to-bone injuries.
Restriction of motor activity due to loss of natural structure is a major cause of decreased life quality in patients suffering from tendon-to-bone injuries.
To solve this problem, the research team, led by the Shanghai Institute of Ceramics (SIC) of the Chinese Academy of Sciences, combined manganese silicate (MS) nanoparticles with tendon/bone-related cells to construct an immunomodulatory multicellular scaffold to achieve integrated tendon-to-bone regeneration.
The scaffold not only demonstrated diverse biological activities in vitro, but also achieved immune regulation, multi-tissue integration regeneration and motor function recovery in a variety of animal models of rotator cuff injury.
The study provides a new concept for achieving immunomodulation and integrated regeneration of tendon-bone and other tissue interfaces, said Wu Chengtie with the SIC, who led the research.
The study was recently published in the journal Science Advances.
(Editor:Fu Bo)
Defensemen injuries are already piling up early in the NHL playoffs
Top of Eiffel Tower reopens to public
Spotlight: U.S. authorities tell int'l students to leave U.S. if universities go online
Key Takeaways from Xi's State Visit to Vietnam
Bayer CEO optimistic about expanding Chinese market
Spotlight: U.S. authorities tell int'l students to leave U.S. if universities go online
Urumqi takes measures to meet residents' need amid efforts to contain COVID
Xi Urges Guangxi to Write Its Chapter in Chinese Modernization
US health officials warn of counterfeit Botox injections
Floods in Bangladesh affect over 1.3 million people